Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2015

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2015			2014			2015			2014

Net sales
Interventional Cardiology	$	567		$	528		$	1,108		$	1,029
Peripheral Interventions	245			210			477			414
Cardiovascular	812			738			1,585			1,443

Cardiac Rhythm Management	490			495			973			959
Electrophysiology	60			55			121			113
Rhythm Management	550			550			1,094			1,072

Endoscopy	352			334			680			650
Urology and Women's Health	142			133			272			259
Neuromodulation	125			114			241			223
MedSurg	619			581			1,193			1,132
Net sales allocated to reportable segments	1,981			1,869			3,872			3,647
Sales generated from divested businesses	—			1			—			3
Impact of foreign currency fluctuations	(138		)	3			(261		)	(3		)
	$	1,843		$	1,873		$	3,611		$	3,647

Income (loss) before income taxes
Cardiovascular	$	247		$	193		$	483		$	364
Rhythm Management	78			67			155			133
MedSurg	188			175			355			343
Operating income allocated to reportable segments	513			435			993			840
Corporate expenses and currency exchange	(105		)	(64		)	(188		)	(115		)
Intangible asset impairment charges; pension termination charges; acquisition-, divestiture-, restructuring-, and litigation-related net charges and credits	(73		)	(331		)	(333		)	(379		)
Amortization expense	(116		)	(109		)	(229		)	(218		)
Operating income (loss)	219			(69		)	243			128
Other expense, net	(114		)	(35		)	(189		)	(86		)
Income (loss) before income taxes	$	105		$	(104	)	$	54		$	42